CJC-1295 With DAC

$89.99

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). This modification was developed to improve stability and extend circulating half-life compared to native GHRH, potentially resulting in longer stimulation of growth hormone release. By binding to albumin in the bloodstream, the DAC component may reduce enzymatic degradation and renal clearance, thereby sustaining biological activity.

Category:

Description

About CJC-1295 With DAC

CJC-1295 DAC contains a Drug Affinity Complex modification that allows researchers to explore how structural changes influence peptide behavior and biological activity. The DAC component has been investigated for its ability to bind with albumin, which may contribute to improved stability and longer-lasting activity in research models.

Metalink Peptides provides CJC 1295 DAC as a research-grade compound with a focus on quality, consistency, and transparency. Each product is intended exclusively for laboratory research and is supplied for scientific investigation purposes only.

Unauthorized health products have not been evaluated or approved by Health Canada. As a result, their safety, effectiveness, and quality are unknown, and they may pose serious health risks. These products may contain dangerous ingredients — including prescription or controlled substances — as well as additives or contaminants that may not appear on the label. The amount of active ingredients may also differ from what is claimed, and they can interact with medications or foods.

 

Prescription drugs are intended to treat specific medical conditions and can cause serious side effects, which is why they should only be used under the supervision of a licensed health care professional. In Canada, prescription drugs can only be legally sold to consumers with a valid prescription.

Reviews

There are no reviews yet.

Be the first to review “CJC-1295 With DAC”